Global Genotyping Market By Product Overview
Introduction:
Genotype, the genetic constitution of an individual, genotyping is the process of determining differences in the genetic make-up of an individual by examining the individual's DNA sequence using biological assays and comparing it to another individual's sequence or a reference sequence. The genotype determines the hereditary potentials and limitations of an individual from embryonic formation through adulthood. It identifies small changes in genetic component within individuals. It has broad range of applications in scientific research, medicine, and agriculture. There are three distinct types of genotypes: homozygous dominant, homozygous recessive, and heterozygous. The technological advancement helps in minimize errors and generating effective results and depicted to enhance the penetration rates of these products. The surge in genetic disorders such as Parkinson’s, turner syndrome and Alzheimer’s had a high impact on the market growth. Providing rapid sequencing and early diagnosis helps in the better aid of such disease by healthcare professionals. The global genotyping market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 21.5 billion by 2030 and is anticipated to register a CAGR of 19.8%.
Global Genotyping Market By Product Dynamics
Drivers: Rising cases of Genetic Diseases
The upsurge in the genetical disorders among individuals across the globe such as Parkinson’s, Alzheimer’s, hemophilia, thalassemia and turner syndrome are driving growth of the global genotyping market. In addition, technological developments in DNA sequencing boost the growth of the target market. Deteriorating prices of DNA sequencing is expected to accelerate growth of the global market over the forecast period.
Restraints: Rising Significance of SNP genotyping
The SNP genotyping is hampering growth of the global growth market. In addition, unfavorable reimbursement policies may also hamper growth of the global market over the forecast period
Global Genotyping Market By Product Segmentation
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The global genotyping market is segmented based on product, technology, application, and region.
Based on product, the global genotyping market is segmented into genotyping instruments, genotyping reagents & kits, and genotyping services. In 2015, the reagents & kits segment held the largest market share in terms of revenue. This is mainly attributed due to wide usage rate and the continually surging demand for the genotyping tests. Easy availability and cost-effectiveness of the reagents are anticipated to significantly impact the genotyping market growth. Based on technology, the global target market is bifurcated into PCR, capillary electrophoresis, mass spectrometry, sequencing, and microarray. PCR technology segment is anticipated to be the fastest growing segment over the forecast period. Various developments in the present sequencing technologies have led to drive growth of the global market. Based on application, the global market is bifurcated into diagnostics, drug discovery & development, personalized medicine, academic research, and agriculture. Personalized medicine application segment is anticipated to witness the fastest growth over the forecast period due to growing government support for personalized medicine and the rising adoption of sequencing for genetic mapping. Based on the basis of regions include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Regional Insights:
The global genotyping market accounted for US$ 3.6 billion in 2020 and is estimated to be US$ 21.5 billion by 2030 and is anticipated to register a CAGR of 19.8%.
On region the global genotyping market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global genotyping market was dominated by North America in 2015 and is expected to maintain its dominance over the forecast period. Rapid advancements in technology and well-established healthcare infrastructure present in this region are the key factors boosting growth of the global market. In addition, growing awareness among people about personalized medicines and the increasing demand for products and services pertaining to genetic testing is also driving growth of the target market in this region. The Asia Pacific region is also projected to grow at the highest growth rate over the forecast period. Introduction of favorable healthcare reforms, growing economic stability, high disposable income, and the presence of untapped market opportunities are the major factors contributing to the regional growth
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product- Genotyping Instruments, Genotyping Reagents & Kits, Genotyping Services By Technology- PCR, Capillary Electrophoresis, Mass Spectrometry, Sequencing, and Microarray By Application– Diagnostics, Drug Discovery & Development, Personalized Medicine, Academic Research, and Agriculture |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global genotyping market report based on product, technology, application, and region.
Global Genotyping Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Genotyping Market By Product Key Players
The key players operating the global genotyping market involves GE Healthcare, Affymetrix, Inc., Beckman Coulter, Inc., Agilent Technologies, Inc., Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, Roche Diagnostics, Qiagen NV, and Vertex Pharmaceuticals. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. In June 2019, Vertex Pharmaceuticals Incorporated announced the approval of symdeko by U.S. Food and Drug Administration (FDA) for the treatment of children of ages 6-11 years suffering from cystic fibrosis. In addition, with this approval, dosage strength of symdeko tablets is also available now.
Global Genotyping Market By Product Company Profile
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Affymetrix Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Beckman Coulter Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Agilent Technologies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fluidigm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Illumina Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Life Technologies Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Qiagen NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Vertex Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Genotyping Market By Product Table of Contents
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Genotyping Market, By Product, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Genotyping Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Genotyping Reagents & Kits
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Genotyping Services
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Genotyping Market, By Technology, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- PCR
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Capillary Electrophoresis
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Mass Spectrometry
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Sequencing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Microarray
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Genotyping Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Diagnostics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Drug Discovery & Development
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Personalized Medicine
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Academic Research
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Agriculture
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Genotyping Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Affymetrix, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Fluidigm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Life Technologies Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Qiagen NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Vertex Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- GE Healthcare
-
- Section
- Research Methodology
- About Us
- Contact
FAQs
The global genotyping market is segmented based on product, technology, application, and region.
Rising cases of genetic diseases among individuals across the globe are driving growth of the global genotyping market.
The global genotyping market was dominated by North America in 2015 and is expected to maintain its dominance over the forecast period. Rapid advancements in technology and well-established healthcare infrastructure present in this region are the key factors boosting growth of the global market.
Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. In June 2019, Vertex Pharmaceuticals Incorporated announced the approval of symdeko by U.S. Food and Drug Administration (FDA) for the treatment of children of ages 6-11 years suffering from cystic fibrosis.